Skip to content

To study risk factors, etiology and management of cancer endometrium

CLINICOPATHOLOGICAL STUDY OF CARCINOMA ENDOMETRIUM - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/01/079390
Enrollment
30
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Control Intervention1: Nil: Nil

Sponsors

Lok Nayak Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Histopathological confirmed cases of carcinoma endometrium (retrospective cases of last one year and prospective cases visiting OPD)

Exclusion criteria

Exclusion criteria: • Metastatic tumors of endometrium from ovary and cervix

Design outcomes

Primary

MeasureTime frame
Demographic and clinicopathological profile of patients with endometrial carcinoma and Treatment modalities (surgery and/or Radiotherapy or chemotherapy or palliative therapy) and response of treatment of patients diagnosed with endometrial cancer at Lok Nayak hospital Timepoint: Demographic and clinicopathological profile of patients with endometrial carcinoma visiting Lok Nayak hospital and Treatment modalities (surgery and/or Radiotherapy or chemotherapy or palliative therapy) and response of treatment 6weeks after surgery of patients diagnosed with endometrial cancer at Lok Nayak hospital and 12months follow up post treatment for any short term complications and residual disease

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactLatika Sahu

Lok Nayak Hospital

Latikasahu@gmail.com9968604400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026